Request Appointment
160 East 53rd StreetNew York, NY 10022
Overview of Dr. Santomasso
Dr. Bianca Santomasso is a neurologist in New York, NY and is affiliated with Memorial Sloan Kettering Cancer Center. She received her medical degree from Weill Cornell Medicine and has been in practice 9 years. She is one of 62 doctors at Memorial Sloan Kettering Cancer Center who specialize in Neurology. She has more than 40 publications and over 500 citings.
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 2009 - 2013
- Weill Cornell MedicineClass of 2008
Certifications & Licensure
- NY State Medical License 2013 - 2026
- NJ State Medical License 2020 - 2025
- American Board of Psychiatry and Neurology Neurology
- UCNSNeuro-Oncology
Publications & Presentations
PubMed
- Severe toxicity, but long-term persistence of CAR T cells after immune checkpoint inhibitors in large B-cell lymphoma.Xavier Deschênes-Simard, Martina Pennisi, Miguel-Angel Perales, Gunjan L Shah, Andrew D Zelenetz
Leukemia & Lymphoma. 2025-03-01 - EEG features and synek scale indicate severity of neurotoxicity in adult patients treated with CD19 CAR T-cell therapy.David Mao, Anne S Reiner, Xi Chen, Jae Park, Martina Pennisi
Scientific Reports. 2024-11-23 - 2 citationsClinical features, pathophysiology, and management of acute myelopathy following CAR T-cell therapy.Xavier Deschênes-Simard, Bianca D Santomasso, Parastoo B Dahi
Blood. 2024-11-14
Abstracts/Posters
- Easix and Modified-Easix Are Early Predictors of Severe Cytokine Release Syndrome and Neurotoxicity in Patients Treated with Chimeric Antigen Receptor T CellsBianca Santomasso, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Impact and Safety of Chimeric Antigen Receptor T Cell Therapy in Vulnerable Older Patients with Relapsed/Refractory Diffuse Large B-Cell LymphomaBianca Santomasso, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Hematological Count Recovery in Patients Undergoing Treatment with Chimeric Antigen Receptor T Cells (CAR T)Bianca Santomasso, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Join now to see all
Lectures
- Neurotoxicity From CAR T-Cell Therapy: Why It Happens, How to Manage It, and Who Is at Risk?ASCO Annual Meeting 2019 - Chicago, IL - 5/31/2019
- Neurologic immune related adverse events (irAEs) in patients treated with immune checkpoint blockade.2018 ASCO Annual Meeting - Chicago, Illinois - 06/4/2018
Press Mentions
- Incysus Announces Formation of Scientific Advisory BoardAugust 24th, 2017
- Incysus Announces Appointment of Siraj Ali, MD, PhD to Its Scientific Advisory BoardJanuary 12th, 2017
Grant Support
- Comprehensive Molecular and Clinical Characterization of Acute and Chronic Neurotoxicity Following CAR-T Cell TherapySLOAN-KETTERING INST CAN RESEARCH2024–2029
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: